The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Dexcom Inc shares valued at $32,593 were sold by Stern Sadie on Dec 16 ’24. At $76.87 per share, Stern Sadie sold 424 shares. The insider’s holdings dropped to 70,768 shares worth approximately $5.7 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Sylvain Jereme M sold 744 shares, netting a total of over 57,191 in proceeds. Following the sale of shares at $76.87 each, the insider now holds 80,030 shares.
Before that, Leach Jacob Steven had sold 744 shares from its account. In a trade valued at $57,191, the EVP, Chief Operating Officer traded Dexcom Inc shares for $76.87 each. Upon closing the transaction, the insider’s holdings decreased to 744 shares, worth approximately $21.28 million.
As published in a research note from Robert W. Baird on July 26, 2024, Dexcom Inc [DXCM] has been rated down from an Outperform to a Neutral and the price target has been revised to $80 from $161. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late July. As of May 30, 2024, Redburn Atlantic has initiated its “Neutral” rating for DXCM. Earlier on March 12, 2024, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for DXCM stock.
Analyzing DXCM Stock Performance
During the last five days, there has been a surge of approximately 7.06%. Over the course of the year, Dexcom Inc shares have dropped approximately -35.07%. Shares of the company reached a 52-week high of $142.00 on 03/26/24 and a 52-week low of $62.34 on 07/26/24. A 50-day SMA is recorded $75.05, while a 200-day SMA reached $96.70. Nevertheless, trading volume fell to 1.35 million shares from 2.36 million shares the previous day.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 79.66, which, if violated, would cause prices to drop to 78.74. In the upper region, resistance lies at 81.08. The next price resistance is at 81.58. RSI (Relative Strength Index) is 59.55 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.70, which suggests the price will increase in the coming days. Percent R is at 13.41%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
